loader

Green Pill_Apr’24

The XVI Volume of The Green Pill explores the emerging fault lines in the ESG landscape, with pro- and anti- ESG pThe XVI Volume of The Green Pill explores the emerging fault lines in the ESG landscape, with pro- and anti- ESG proponents making their voices more shrill. This comes in the backdrop of the investment performance of anti-ESG assets and claims by certain quarters that investors ought to focus on returns, firstly and lastly. The volume explores the paths being taken by gung-ho regulators, contrasting them to various shades of the anti-ESG movement, and calls for effective leadership to avert the crisis.

Subscribe

    Subscribe to content and reports from SBICAPS


    Fields marked with an asterisk (*) are required.






    Accessibility Controls

    Color Contrast

    High contrast background & text

    Screen Reader

    Hover-to-speech English voice assistant

    Keyboard Nav

    Enhanced tab focus outline & skip link

    Video

    Pauses sliders, animations & media players

    Other Helpers

    Enlarges cursor & highlights active links

    Zoom Scaling

    Adjust core sizing level (-4px to +8px)

    Default